BUY Piramal Pharma Limited — Hem Securities
byHem SecuritiesHorizon: NA (inferred 1 year)20 May 2024via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·28 Jul · 2d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Piramal Pharma
- BUY — Nirav Chheda, Nirmal Bang Securities24 Sept 2026 · ~1 year · target ₹250 · Active
- BUY — Rakesh Bansal24 Sept 2026 · Same day · target ₹219 · SL hit
- BUY — Goldman Sachs24 Sept 2026 · ~1 year · target ₹250 · Active
- BUY — Sacchitanand Uttekar, Tradebulls Securities22 Sept 2026 · ~3 months · target ₹230 · SL hit
- BUY — Siddharth Rai Mangala21 Sept 2026 · ~2 weeks · target ₹230 · SL hit
More from Hem Securities
- BUY Allied Blenders and Distillers11 Jun 2026 · ~3 months · target ₹655 · Target hit
- BUY CSB Bank14 Nov 2024 · ~1 year · target ₹350 · Target hit
- BUY S.J.S. Enterprises6 Nov 2024 · ~1 year · target ₹1,458 · Target hit
- BUY Power Grid Corporation of India5 Nov 2024 · ~1 year · target ₹365 · Expired
- BUY Shyam Metalics and Energy28 Oct 2024 · ~1 year · target ₹956 · Target hit

